首页> 外文OA文献 >Inhibition to Epithelial-Mesenchymal Transition and Metastatic Potential In Colorectal Cancer Cell By Combination of Traditional Chinese Medicine Formulation Jiedu Sangen Decoction and PD-L1 Inhibitor

【2h】

Inhibition to Epithelial-Mesenchymal Transition and Metastatic Potential In Colorectal Cancer Cell By Combination of Traditional Chinese Medicine Formulation Jiedu Sangen Decoction and PD-L1 Inhibitor

机译：通过中药制剂Jiedu Sangen汤和PD-L1抑制剂的组合抑制结肠直肠癌细胞的上皮 - 间充质转变和转移性潜力

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Feiyu Shan; Leitao Sun; Leyin Zhang; Kaibo Guo; Qingying Yan; Guan Feng; Ying Zhu; Minhe Shen; Shanming Ruan;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Inhibition to Epithelial-Mesenchymal Transition and Metastatic Potential In Colorectal Cancer Cell By Combination of Traditional Chinese Medicine Formulation Jiedu Sangen Decoction and PD-L1 Inhibitor [J] . Feiyu Shan, Leitao Sun, Leyin Zhang, Integrative cancer therapies. . 2020,第1期

机译：通过中药制剂Jiedu Sangen汤和PD-L1抑制剂的组合抑制结肠直肠癌细胞的上皮 - 间充质转变和转移性潜力
2. Traditional Chinese medicine formulation Yanggan Jiedu Sanjie inhibits TGF-β1-induced epithelial-mesenchymal transition and metastatic potential in human hepatocarcinoma Bel-7402 cells [J] . Bing Hu, Hong-Mei An, Xia Yan, BMC Complementary and Alternative Medicine . 2019,第1期

机译：中药制剂养肝解毒散结抑制人肝癌Bel-7402细胞中TGF-β1诱导的上皮-间质转化和转移潜能
3. Jiedu Sangen Decoction Inhibits the Invasion and Metastasis of Colorectal Cancer Cells by Regulating EMT through the Hippo Signaling Pathway [J] . Li Yuan, Mengmeng Zhou, Harpreet S. Wasan, Evidence-based complementary and alternative medicine: eCAM . 2019,第9期

机译：Jiedu Sangen汤剂通过通过河马信号通路调节EMT来抑制结直肠癌细胞的侵袭和转移
4. The Potential Dual-target Inhibitors for HER2/HSP90 Proteins from Traditional Chinese Medicine [C] . Jhih-Ying Chen, Chia-Min Chen, Pei-Chun Chang, IEEE International Conference on Bioinformatics and Bioengineering . 2018

机译：来自中医的HER2 / HSP90蛋白的潜在双靶抑制剂
5. Screening of IRE1α Ribonuclease Inhibitors from Traditional Chinese Medicine and Underlying Anticancer Mechanisms Study [D] . Xie, Jing. 2021

机译：筛选来自中药和抗癌机制研究的IRE1α核糖核酸酶抑制剂
6. Inhibition to Epithelial-Mesenchymal Transition and MetastaticPotential In Colorectal Cancer Cell By Combination of Traditional ChineseMedicine Formulation Jiedu Sangen Decoction and PD-L1 Inhibitor [O] . Feiyu Shan, Leitao Sun, Leyin Zhang, 2020

机译：抑制上皮 - 间充质转变和转移性中式常规癌细胞的潜力医学配方Jiedu Sangen汤剂和PD-L1抑制剂
7. Traditional Chinese medicine formulation Yanggan Jiedu Sanjie inhibits TGF-β1-induced epithelial-mesenchymal transition and metastatic potential in human hepatocarcinoma Bel-7402 cells [O] . Bing Hu, Hong-Mei An, Xia Yan, 2019

机译：中药配方杨甘·杰渡三杰抑制了人肝癌BEL-7402细胞中的TGF-β1诱导的上皮 - 间充质转换和转移潜力

Inhibition to Epithelial-Mesenchymal Transition and Metastatic Potential In Colorectal Cancer Cell By Combination of Traditional Chinese Medicine Formulation Jiedu Sangen Decoction and PD-L1 Inhibitor

著录项

引文网络

相似文献

相关主题

期刊订阅